v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (668,564) $ (758,088)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 1,363 1,523
Stock based compensation 50,000 37,500
Accretion of debt discount 27,704 43,207
Accretion of original issuance costs 94,353 83,399
Modification of warrants
Changes in operating assets and liabilities:    
Other current assets 3,900 4,783
Accounts payable 63,656 67,804
Accrued payroll and payroll taxes 136,174 285,908
Other current liabilities (3,032) (1,648)
Net cash used in operating activities (294,446) (235,612)
Cash flows from investing activities:    
None
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from short-term convertible notes 295,197 251,760
Advance from shareholder 25,000
Repayments of advance from shareholder (20,000)
Net cash provided by financing activities 295,197 256,760
Net (decrease) increase in cash 751 21,148
Cash at beginning of period 12,144 11,690
Cash at end of period 12,895 32,838
Cash paid during the period for:    
Interest
Income taxes
Non-cash investing and financing activities:    
Subscription receivable in conjunction with debt issuance 50,000
Warrants issued to third parties in conjunction with debt issuance 130,981 111,834
Original issue discount issued in conjunction with debt $ 34,520 $ 25,176

Source